Selected Scientific Publications from the Morgan Welch Inflammatory Breast Cancer Program
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
Yang WT, Le-Petross HT, Macapinlac H, Carkaci S, Gonzalez-Angulo AM, Dawood S, Resetkova E, Hortobagyi GN, Cristofanilli M.
Breast Cancer Res Treat. 2008 Jun;109(3):417-26. Epub 2007 Jul 26. Review.
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
Carkaci S, Macapinlac HA, Cristofanilli M, Mawlawi O, Rohren E, Gonzalez Angulo AM, Dawood S, Resetkova E, Le-Petross HT, Yang WT.
J Nucl Med. 2009 Feb;50(2):231-8. Epub 2009 Jan 21.
Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells.
Mandal PK, Freiter EM, Bagsby AL, Robertson FM, McMurray JS.
Bioorg Med Chem Lett. 2011 Oct 15;21(20):6071-3. Epub 2011 Aug 19.
Genomic and Proteomic Pathway Mapping 3 Reveals Signatures of Mesenchymal-Epithelial 4 Plasticity in Inflammatory Breast Cancer.
Fredika M. Robertson et al.
Breast Cancer - Recent Advances in Biology, Imaging and Therapeutics. Croatia, 2011
Local-regional treatment outcomes after multimodality management of inflammatory breast cancer.
Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Tereffe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA.
Int J Radiat Oncol Biol Phys 72(2):474-84, 10/2008. e-Pub 4/2008.
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer.
Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA.
The Oncologist. In Press.
Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.
Singh B, Cook KR, Martin C, Huang EH, Mosalpuria K, Krishnamurthy S, Cristofanilli M, Lucci A.
Clin Exp Metastasis 27(4):233-40, 4/2010. e-Pub 3/2010.
Disseminated tumor cells in biologic subtypes of Stage I-III breast cancer patients.
Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci A.
Ann Surg Oncol 17(12):3252-3258, 12/2010. e-Pub 6/2010.
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer.
Zhang, D, LaFortune, TA, Krishnamurthy, S, Esteva, FJ, Cristofanilli, M, Liu, P, Lucci, A, et al.
Clin Cancer Res. 2009 Nov 1;15(21):6639-48. Epub 2009 Oct 13.
Targeted therapy in inflammatory breast cancer.
Yamauchi, H, Ueno, NTT.
Cancer, 116(11 Suppl), 2758–2759.
MRI features of inflammatory breast cancer.
Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S, Jackson EF, Harrell RK, Reed BJ, Yang WT..
AJR Am J Roentgenol. 2011 Oct;197(4):W769-76.
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer.
Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA, Reuben JM, Matsuoka J, Gong Y, Krishnamurthy S, Valero V, Hortobagyi GN, Robertson F, Symmans WF, Pusztai L, Ueno NT.
Breast Cancer Res Treat. 2011 Feb;125(3):785-95. Epub 2010 Dec 9.
Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells.
Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, Li L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, Cristofanilli M, Marini F, Andreeff M, Woodward WA.
PLoS One. 2010 Aug 16;5(8):e12180.
Overcoming radiation resistance in inflammatory breast cancer.
Woodward WA, Debeb BG, Xu W, Buchholz TA.
Cancer. 2010 Jun 1;116(11 Suppl):2840-5.
Identifying factors that impact survival among women with inflammatory breast cancer.
Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Cristofanilli M.
Ann Oncol. 2011 Jul 15. [Epub ahead of print]
Incidence of and survival following brain metastases among women with inflammatory breast cancer.
Dawood S, Ueno NT, Valero V, Andreopoulou E, Hsu L, Lara J, Woodward W, Buchholz TA, Hortobagyi GN, Cristofanilli M.
Ann Oncol. 2010 Dec;21(12):2348-55. Epub 2010 May 3.